US Stock MarketDetailed Quotes

SNOA Sonoma Pharmaceuticals

Watchlist

2.6300
+0.0800+3.14%

Close Dec 20 16:00 ET

2.6300
0.00000.00%

Post 20:01 ET

3.52MMarket Cap-2.66P/E (TTM)

Sonoma Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Sep 30, 2024

(Q1)Jun 30, 2024

(FY)Mar 31, 2024

(Q4)Mar 31, 2024

(Q3)Dec 31, 2023

(Q2)Sep 30, 2023

(Q1)Jun 30, 2023

(FY)Mar 31, 2023

(Q4)Mar 31, 2023

(Q3)Dec 31, 2022

Total revenue

31.05%3.58M

-1.05%3.39M

-4.05%12.74M

14.10%3.44M

6.59%3.14M

-18.01%2.73M

-13.96%3.43M

5.10%13.27M

31.16%3.01M

1.45%2.94M

Operating revenue

31.05%3.58M

-1.05%3.39M

-4.05%12.74M

14.10%3.44M

6.59%3.14M

-18.01%2.73M

-13.96%3.43M

5.10%13.27M

31.16%3.01M

1.45%2.94M

Cost of revenue

27.40%2.22M

-6.21%2.09M

-9.15%7.99M

9.21%2.35M

-20.59%1.68M

-3.01%1.74M

-4.88%2.22M

1.85%8.8M

-2.36%2.15M

24.37%2.11M

Gross profit

37.47%1.36M

8.47%1.31M

5.99%4.75M

26.27%1.09M

75.69%1.46M

-35.55%990K

-26.85%1.2M

12.12%4.48M

800.00%864K

-30.92%831K

Operating expense

0.59%2.21M

1.43%2.48M

4.41%9.45M

24.32%2.5M

-13.55%2.3M

-3.04%2.2M

-2.28%2.44M

-8.43%9.05M

-36.28%2.01M

23.32%2.67M

Selling and administrative expenses

2.59%1.71M

-5.19%2.01M

-14.31%7.58M

15.52%2.09M

-36.10%1.7M

-19.59%1.66M

-7.67%2.12M

-9.38%8.84M

-42.58%1.81M

24.82%2.67M

Research and development costs

-5.60%506K

44.62%470K

803.86%1.87M

103.48%409K

--601K

168.00%536K

57.77%325K

65.60%207K

4,925.00%201K

--0

Operating profit

29.64%-850K

5.40%-1.17M

-2.87%-4.7M

-22.84%-1.41M

53.98%-844K

-65.25%-1.21M

-45.03%-1.24M

22.37%-4.57M

62.52%-1.15M

-91.44%-1.83M

Net non-operating interest income expense

Other net income (expense)

530.00%387K

183.41%176K

46.25%-330K

117.12%50K

-11.27%-79K

51.61%-90K

-214.93%-211K

-228.18%-614K

-37.09%-292K

-745.45%-71K

Other non- operating income (expenses)

530.00%387K

183.41%176K

46.25%-330K

117.12%50K

-11.27%-79K

51.61%-90K

-214.93%-211K

-55.84%-614K

68.80%-292K

-745.45%-71K

Income before tax

64.33%-463K

31.29%-997K

2.95%-5.03M

5.56%-1.36M

51.55%-923K

-41.55%-1.3M

-57.38%-1.45M

4.32%-5.18M

56.15%-1.44M

-101.80%-1.91M

Income tax

-20.97%147K

542.42%146K

-493.94%-196K

-122.90%-292K

-267.65%-57K

86.00%186K

5.71%-33K

90.06%-33K

61.24%-131K

34K

Net income

58.89%-610K

19.39%-1.14M

6.13%-4.84M

18.43%-1.07M

55.34%-866K

-45.92%-1.48M

-59.86%-1.42M

-1.28%-5.15M

55.57%-1.31M

-105.40%-1.94M

Net income continuous Operations

58.89%-610K

19.39%-1.14M

6.13%-4.84M

18.43%-1.07M

55.34%-866K

-45.92%-1.48M

-59.86%-1.42M

-1.28%-5.15M

55.57%-1.31M

-105.40%-1.94M

Minority interest income

Net income attributable to the parent company

58.89%-610K

19.39%-1.14M

6.13%-4.84M

18.43%-1.07M

55.34%-866K

-45.92%-1.48M

-59.86%-1.42M

-1.28%-5.15M

55.57%-1.31M

-105.40%-1.94M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

58.89%-610K

19.39%-1.14M

6.13%-4.84M

18.43%-1.07M

55.34%-866K

-45.92%-1.48M

-59.86%-1.42M

-1.28%-5.15M

55.57%-1.31M

-105.40%-1.94M

Basic earnings per share

89.74%-0.59

75.86%-1.4

65.13%-10.6

75.58%-1.3673

87.10%-1.6

12.88%-5.75

0.00%-5.8

20.83%-30.4

73.83%-5.6

-100.00%-12.4

Diluted earnings per share

89.74%-0.59

75.86%-1.4

65.13%-10.6

75.58%-1.3673

87.10%-1.6

12.88%-5.75

0.00%-5.8

20.83%-30.4

73.83%-5.6

-100.00%-12.4

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Sep 30, 2024	(Q1)Jun 30, 2024	(FY)Mar 31, 2024	(Q4)Mar 31, 2024	(Q3)Dec 31, 2023	(Q2)Sep 30, 2023	(Q1)Jun 30, 2023	(FY)Mar 31, 2023	(Q4)Mar 31, 2023	(Q3)Dec 31, 2022
Total revenue	31.05%3.58M	-1.05%3.39M	-4.05%12.74M	14.10%3.44M	6.59%3.14M	-18.01%2.73M	-13.96%3.43M	5.10%13.27M	31.16%3.01M	1.45%2.94M
Operating revenue	31.05%3.58M	-1.05%3.39M	-4.05%12.74M	14.10%3.44M	6.59%3.14M	-18.01%2.73M	-13.96%3.43M	5.10%13.27M	31.16%3.01M	1.45%2.94M
Cost of revenue	27.40%2.22M	-6.21%2.09M	-9.15%7.99M	9.21%2.35M	-20.59%1.68M	-3.01%1.74M	-4.88%2.22M	1.85%8.8M	-2.36%2.15M	24.37%2.11M
Gross profit	37.47%1.36M	8.47%1.31M	5.99%4.75M	26.27%1.09M	75.69%1.46M	-35.55%990K	-26.85%1.2M	12.12%4.48M	800.00%864K	-30.92%831K
Operating expense	0.59%2.21M	1.43%2.48M	4.41%9.45M	24.32%2.5M	-13.55%2.3M	-3.04%2.2M	-2.28%2.44M	-8.43%9.05M	-36.28%2.01M	23.32%2.67M
Selling and administrative expenses	2.59%1.71M	-5.19%2.01M	-14.31%7.58M	15.52%2.09M	-36.10%1.7M	-19.59%1.66M	-7.67%2.12M	-9.38%8.84M	-42.58%1.81M	24.82%2.67M
Research and development costs	-5.60%506K	44.62%470K	803.86%1.87M	103.48%409K	--601K	168.00%536K	57.77%325K	65.60%207K	4,925.00%201K	--0
Operating profit	29.64%-850K	5.40%-1.17M	-2.87%-4.7M	-22.84%-1.41M	53.98%-844K	-65.25%-1.21M	-45.03%-1.24M	22.37%-4.57M	62.52%-1.15M	-91.44%-1.83M
Net non-operating interest income expense
Other net income (expense)	530.00%387K	183.41%176K	46.25%-330K	117.12%50K	-11.27%-79K	51.61%-90K	-214.93%-211K	-228.18%-614K	-37.09%-292K	-745.45%-71K
Other non- operating income (expenses)	530.00%387K	183.41%176K	46.25%-330K	117.12%50K	-11.27%-79K	51.61%-90K	-214.93%-211K	-55.84%-614K	68.80%-292K	-745.45%-71K
Income before tax	64.33%-463K	31.29%-997K	2.95%-5.03M	5.56%-1.36M	51.55%-923K	-41.55%-1.3M	-57.38%-1.45M	4.32%-5.18M	56.15%-1.44M	-101.80%-1.91M
Income tax	-20.97%147K	542.42%146K	-493.94%-196K	-122.90%-292K	-267.65%-57K	86.00%186K	5.71%-33K	90.06%-33K	61.24%-131K	34K
Net income	58.89%-610K	19.39%-1.14M	6.13%-4.84M	18.43%-1.07M	55.34%-866K	-45.92%-1.48M	-59.86%-1.42M	-1.28%-5.15M	55.57%-1.31M	-105.40%-1.94M
Net income continuous Operations	58.89%-610K	19.39%-1.14M	6.13%-4.84M	18.43%-1.07M	55.34%-866K	-45.92%-1.48M	-59.86%-1.42M	-1.28%-5.15M	55.57%-1.31M	-105.40%-1.94M
Minority interest income
Net income attributable to the parent company	58.89%-610K	19.39%-1.14M	6.13%-4.84M	18.43%-1.07M	55.34%-866K	-45.92%-1.48M	-59.86%-1.42M	-1.28%-5.15M	55.57%-1.31M	-105.40%-1.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	58.89%-610K	19.39%-1.14M	6.13%-4.84M	18.43%-1.07M	55.34%-866K	-45.92%-1.48M	-59.86%-1.42M	-1.28%-5.15M	55.57%-1.31M	-105.40%-1.94M
Basic earnings per share	89.74%-0.59	75.86%-1.4	65.13%-10.6	75.58%-1.3673	87.10%-1.6	12.88%-5.75	0.00%-5.8	20.83%-30.4	73.83%-5.6	-100.00%-12.4
Diluted earnings per share	89.74%-0.59	75.86%-1.4	65.13%-10.6	75.58%-1.3673	87.10%-1.6	12.88%-5.75	0.00%-5.8	20.83%-30.4	73.83%-5.6	-100.00%-12.4
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Heat List

Overall

No Data